Cargando…
Inhibition of pro-inflammatory signaling in human primary macrophages by enhancing arginase-2 via target site blockers
The modulation of macrophage phenotype from a pro-inflammatory to an anti-inflammatory state holds therapeutic potential in the treatment of inflammatory disease. We have previously shown that arginase-2 (Arg2), a mitochondrial enzyme, is a key regulator of the macrophage anti-inflammatory response....
Autores principales: | Fitzsimons, Stephen, Muñoz-San Martín, María, Nally, Frances, Dillon, Eugene, Fashina, Ifeolutembi A., Strowitzki, Moritz J., Ramió-Torrentà, Lluís, Dowling, Jennifer K., De Santi, Chiara, McCoy, Claire E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494319/ https://www.ncbi.nlm.nih.gov/pubmed/37701067 http://dx.doi.org/10.1016/j.omtn.2023.08.023 |
Ejemplares similares
-
Enhancing arginase 2 expression using target site blockers as a strategy to modulate macrophage phenotype
por: De Santi, Chiara, et al.
Publicado: (2022) -
In silico prioritisation of microRNA-associated common variants in multiple sclerosis
por: Fashina, Ifeolutembi A., et al.
Publicado: (2023) -
Nanomodulation of Macrophages in Multiple Sclerosis
por: Nally, Frances K., et al.
Publicado: (2019) -
Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages
por: Dowling, Jennifer K., et al.
Publicado: (2021) -
Clinical and radiological features of cerebral amyloid angiopathy-related inflammation
por: Bravo, Gary Álvarez, et al.
Publicado: (2021)